Does Ultrasound Guidance Improve the Effectiveness of Neurotoxin Injections in Patients with Cervical Dystonia? (A Prospective, Partially-Blinded, Clinical Study)
暂无分享,去创建一个
[1] L. Defebvre,et al. Does ultrasound-guidance improve the outcome of botulinum toxin injections in cervical dystonia? , 2021, Revue Neurologique.
[2] W. Jost,et al. Botulinum neurotoxin in cervical dystonia revisited - recent advances and unanswered questions. , 2021, Neurologia i neurochirurgia polska.
[3] D. Dressler,et al. Dysphagia in cervical dystonia patients receiving optimised botulinum toxin therapy: a single-center retrospective cohort study , 2020, Journal of Neural Transmission.
[4] L. Defebvre,et al. Anatomy‐guided injections of botulinum neurotoxin in neck muscles: how accurate is needle placement? , 2020, European journal of neurology.
[5] W. Jost,et al. Cervical dystonia - improving the effectiveness of botulinum toxin therapy. , 2020, Neurologia i neurochirurgia polska.
[6] W. Jost,et al. Preferred muscles in cervical dystonia. , 2020, Neurologia i Neurochirurgia Polska.
[7] W. Jost,et al. Injection into the Longus Colli Muscle via the Thyroid Gland , 2019, Tremor and other hyperkinetic movements.
[8] I. Odderson,et al. Ultrasound and Electromyography Guidance for Injection of the Longus Colli With Botulinum Toxin for the Treatment of Cervical Dystonia. , 2016, Ultrasound quarterly.
[9] S. Factor,et al. Botulinum toxin treatment failures in cervical dystonia: causes, management, and outcomes , 2016, Journal of Neurology.
[10] W. Jost,et al. Selection of Muscles for Botulinum Toxin Injections in Cervical Dystonia , 2015, Movement disorders clinical practice.
[11] C. Colosimo,et al. Factors influencing secondary non-response to botulinum toxin type A injections in cervical dystonia. , 2015, Parkinsonism & related disorders.
[12] W. Jost,et al. Relevance of sonography for botulinum toxin treatment of cervical dystonia: an expert statement , 2014, Journal of Neural Transmission.
[13] M. Munin,et al. Elimination of dysphagia using ultrasound guidance for botulinum toxin injections in cervical dystonia , 2012, Muscle & nerve.
[14] M. Yokoe,et al. Sonographic guidance provides a low‐risk approach to the longus colli muscle , 2012, Movement disorders : official journal of the Movement Disorder Society.
[15] J. Jankovic,et al. Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE) , 2011, BMC neurology.
[16] R. Bhidayasiri. Treatment of complex cervical dystonia with botulinum toxin: involvement of deep-cervical muscles may contribute to suboptimal responses. , 2011, Parkinsonism & related disorders.
[17] A. Albanese,et al. EFNS guidelines on diagnosis and treatment of primary dystonias , 2011, European journal of neurology.
[18] Y. Yoon,et al. Initial experience with imaging-guided intramuscular botulinum toxin injection in patients with idiopathic cervical dystonia. , 2009, AJR. American journal of roentgenology.
[19] D M Simpson,et al. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) , 2008, Neurology.
[20] R. Barbano,et al. Treatment recommendations and practical applications of botulinum toxin treatment of cervical dystonia. , 2008, Neurologic clinics.
[21] Su Jin Lee,et al. Localization of Dystonic Muscles with 18F-FDG PET/CT in Idiopathic Cervical Dystonia , 2007, Journal of Nuclear Medicine.
[22] C. Comella,et al. Treatment of cervical dystonia with botulinum toxins , 2006, Journal of neural transmission.
[23] J. D. Speelman,et al. Cervical dystonia and botulinum treatment: Is electromyographic guidance necessary? , 1995, Movement disorders : official journal of the Movement Disorder Society.
[24] G. Reichel,et al. Zur Phänomenologie der zervikalen Dystonien Vorschlag einer neuen Behandlungsstrategie mit Botulinumtoxin The Phenomenology of Cervical Dystonia Proposed New Treatment Strategy with Botulinum Toxin , 2009 .
[25] R. Benecke,et al. Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group. , 1999, Journal of neurology.